| Utility: Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders Filling date: 7 Sep 2025 Issue date: 18 Aug 2022 | 11 Oct 2021 | 18 Aug 2022 |
| Utility: Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria Filling date: 7 Sep 2025 Issue date: 4 Aug 2022 | 11 Oct 2021 | 4 Aug 2022 |
| Utility: Anti-Inflammatory and Mydriatic Intracameral Solutions for Inhibition of Postoperative Ocular Inflammatory Conditions Filling date: 7 Sep 2025 Issue date: 9 Jun 2022 | 17 Dec 2021 | 9 Jun 2022 |
| Utility: OPHTHALMOLOGIC IRRIGATION SOLUTIONS AND METHOD Filling date: 7 Sep 2025 Issue date: 9 Jun 2022 | 15 Dec 2021 | 9 Jun 2022 |
| Utility: Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation Filling date: 7 Sep 2025 Issue date: 24 Mar 2022 | 9 Sep 2021 | 24 Mar 2022 |
| Utility: Treatment of Addiction and Impulse-Control Disorders Using PDE7 Inhibitors Filling date: 7 Sep 2025 Issue date: 3 Mar 2022 | 18 Nov 2021 | 3 Mar 2022 |
| Utility: CYCLOOXYGENASE INHIBITOR AND CALCIUM CHANNEL ANTAGONIST COMPOSITIONS AND METHODS FOR USE IN UROLOGICAL PROCEDURES Filling date: 7 Sep 2025 Issue date: 3 Mar 2022 | 11 Nov 2021 | 3 Mar 2022 |
| Utility: MONOCLONAL ANTIBODIES, COMPOSITIONS AND METHODS FOR DETECTING COMPLEMENT FACTOR D Filling date: 7 Sep 2025 Issue date: 24 Feb 2022 | 17 Aug 2021 | 24 Feb 2022 |
| Utility: Anti-inflammatory and mydriatic intracameral solutions for inhibition of postoperative ocular inflammatory conditions Filling date: 7 Sep 2025 Issue date: 1 Feb 2022 | 14 Feb 2019 | 1 Feb 2022 |
| Utility: Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation Filling date: 7 Sep 2025 Issue date: 6 Jan 2022 | 9 Jul 2021 | 6 Jan 2022 |
| Utility: Treatment of addiction and impulse-control disorders using PDE7 inhibitors Filling date: 7 Sep 2025 Issue date: 28 Dec 2021 | 15 Jan 2018 | 28 Dec 2021 |
| Utility: METHODS FOR INHIBITING FIBROSIS IN A SUBJECT IN NEED THEREOF Filling date: 7 Sep 2025 Issue date: 18 Nov 2021 | 30 Mar 2021 | 18 Nov 2021 |
| Utility: Methods for Treating and/or Preventing Graft-Versus-Host Disease and/or Diffuse Alveolar Hemorrhage and/or Veno-Occlusive Disease Associated with Hematopoietic Stem Cell Transplant Filling date: 7 Sep 2025 Issue date: 23 Sep 2021 | 9 Apr 2021 | 23 Sep 2021 |
| Utility: CYCLOOXYGENASE INHIBITOR AND CALCIUM CHANNEL ANTAGONIST COMPOSITIONS AND METHODS FOR USE IN UROLOGICAL PROCEDURES Filling date: 7 Sep 2025 Issue date: 23 Sep 2021 | 6 Apr 2021 | 23 Sep 2021 |
| Utility: Methods of Inhibiting MASP-2 for the Treatment and/or Prevention of Coronavirus-induced Acute Respiratory Distress Syndrome Filling date: 7 Sep 2025 Issue date: 23 Sep 2021 | 5 Mar 2021 | 23 Sep 2021 |
| Utility: ANTIBODIES SPECIFICALLY BINDING TO MASP-3 FOR THE TREATMENT OF VARIOUS DISEASES AND DISORDERS Filling date: 7 Sep 2025 Issue date: 9 Sep 2021 | 27 Apr 2021 | 9 Sep 2021 |
| Utility: Methods of generating bioactive peptide-bearing antibodies and compositions comprising the same Filling date: 7 Sep 2025 Issue date: 29 Jun 2021 | 15 Mar 2017 | 29 Jun 2021 |
| Utility: METHODS FOR INHIBITING ANGIOGENESIS IN A SUBJECT IN NEED THEREOF Filling date: 7 Sep 2025 Issue date: 24 Jun 2021 | 17 Nov 2020 | 24 Jun 2021 |
| Utility: MASP-2 INHIBITORS AND METHODS OF USE Filling date: 7 Sep 2025 Issue date: 17 Jun 2021 | 4 Dec 2020 | 17 Jun 2021 |
| Utility: MASP-2 INHIBITORS AND METHODS OF USE Filling date: 7 Sep 2025 Issue date: 10 Jun 2021 | 4 Dec 2020 | 10 Jun 2021 |
| Utility: MASP-2 INHIBITORS AND METHODS OF USE Filling date: 7 Sep 2025 Issue date: 10 Jun 2021 | 4 Dec 2020 | 10 Jun 2021 |
| Utility: MASP-2 INHIBITORS AND METHODS OF USE Filling date: 7 Sep 2025 Issue date: 10 Jun 2021 | 4 Dec 2020 | 10 Jun 2021 |
| Utility: Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders Filling date: 7 Sep 2025 Issue date: 8 Jun 2021 | 23 Jun 2020 | 8 Jun 2021 |
| Utility: Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrhage and/or veno-occlusive disease associated with hematopoietic stem cell transplant Filling date: 7 Sep 2025 Issue date: 25 May 2021 | 14 Aug 2018 | 25 May 2021 |
| Utility: Methods of Generating Bioactive Peptide-bearing Antibodies and Compositions Comprising the Same Filling date: 7 Sep 2025 Issue date: 18 Mar 2021 | 4 Aug 2020 | 18 Mar 2021 |
| Utility: METHODS FOR INHIBITING FIBROSIS IN A SUBJECT IN NEED THEREOF Filling date: 7 Sep 2025 Issue date: 18 Mar 2021 | 30 Jun 2020 | 18 Mar 2021 |
| Utility: METHODS FOR REDUCING PROTEINURIA IN A HUMAN SUBJECT SUFFERING FROM IMMUNOGLOBULIN A NEPHROPATHY Filling date: 7 Sep 2025 Issue date: 18 Mar 2021 | 25 Jun 2020 | 18 Mar 2021 |
| Utility: Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation Filling date: 7 Sep 2025 Issue date: 25 Feb 2021 | 12 May 2020 | 25 Feb 2021 |
| Utility: COMPOSITIONS FOR INHIBITING MASP-2 DEPENDENT COMPLEMENT ACTIVATION Filling date: 7 Sep 2025 Issue date: 25 Feb 2021 | 24 Apr 2020 | 25 Feb 2021 |
| Utility: Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation Filling date: 7 Sep 2025 Issue date: 18 Feb 2021 | 4 Aug 2020 | 18 Feb 2021 |
| Utility: METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION Filling date: 7 Sep 2025 Issue date: 11 Feb 2021 | 2 Apr 2020 | 11 Feb 2021 |
| Utility: CHIMERIC INHIBITOR MOLECULES OF COMPLEMENT ACTIVATION Filling date: 7 Sep 2025 Issue date: 14 Jan 2021 | 16 Jul 2020 | 14 Jan 2021 |
| Utility: Methods for inhibiting angiogenesis in a subject in need thereof Filling date: 7 Sep 2025 Issue date: 22 Dec 2020 | 31 Mar 2017 | 22 Dec 2020 |
| Utility: Monoclonal Antibodies, Compositions and Methods for Detecting Mucin-like Protein (MLP) as a Biomarker for Ovarian and Pancreatic Cancer Filling date: 7 Sep 2025 Issue date: 26 Nov 2020 | 12 Mar 2020 | 26 Nov 2020 |
| Utility: Methods and Compositions for Treating Cancer Filling date: 7 Sep 2025 Issue date: 5 Nov 2020 | 10 Jan 2020 | 5 Nov 2020 |
| Utility: ANTIBODIES SPECIFICALLY BINDING TO MASP-3 FOR THE TREATMENT OF VARIOUS DISEASES AND DISORDERS Filling date: 7 Sep 2025 Issue date: 8 Oct 2020 | 23 Jun 2020 | 8 Oct 2020 |
| Utility: Inhibitors of GPR174 and Uses Thereof Filling date: 7 Sep 2025 Issue date: 3 Sep 2020 | 13 Nov 2019 | 3 Sep 2020 |
| Utility: NUCLEIC ACIDS ENCODING ANTIBODIES SPECIFICALLY BINDING TO MASP-3 Filling date: 7 Sep 2025 Issue date: 27 Aug 2020 | 1 Apr 2020 | 27 Aug 2020 |
| Utility: Chimeric inhibitor molecules of complement activation Filling date: 7 Sep 2025 Issue date: 25 Aug 2020 | 11 Oct 2017 | 25 Aug 2020 |
| Utility: Nucleic acids encoding antibodies specifically binding to MASP-3 Filling date: 7 Sep 2025 Issue date: 18 Aug 2020 | 1 Apr 2020 | 18 Aug 2020 |
| Utility: Methods for inhibiting fibrosis in a subject in need thereof Filling date: 7 Sep 2025 Issue date: 11 Aug 2020 | 5 Jan 2017 | 11 Aug 2020 |
| Utility: Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation Filling date: 7 Sep 2025 Issue date: 18 Jun 2020 | 13 Sep 2019 | 18 Jun 2020 |
| Utility: Compositions for inhibiting MASP-2 dependent complement activation Filling date: 7 Sep 2025 Issue date: 16 Jun 2020 | 13 Jul 2018 | 16 Jun 2020 |
| Utility: METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION Filling date: 7 Sep 2025 Issue date: 21 May 2020 | 2 Oct 2019 | 21 May 2020 |
| Utility: Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation Filling date: 7 Sep 2025 Issue date: 21 May 2020 | 11 Jul 2019 | 21 May 2020 |
| Utility: Compositions and Methods of Inhibiting MASP-2 for the Treatment of Various Thrombotic Diseases and Disorders Filling date: 7 Sep 2025 Issue date: 7 May 2020 | 20 Jun 2019 | 7 May 2020 |
| Utility: Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders Filling date: 7 Sep 2025 Issue date: 5 May 2020 | 31 Jul 2017 | 5 May 2020 |
| Utility: Monoclonal antibodies, compositions and methods for detecting mucin-like protein (MLP) as a biomarker for ovarian and pancreatic cancer Filling date: 7 Sep 2025 Issue date: 21 Apr 2020 | 6 Jun 2017 | 21 Apr 2020 |
| Utility: Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation Filling date: 7 Sep 2025 Issue date: 13 Feb 2020 | 22 Feb 2019 | 13 Feb 2020 |
| Utility: Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation Filling date: 7 Sep 2025 Issue date: 6 Feb 2020 | 8 Apr 2019 | 6 Feb 2020 |
